Compared with placebo, the new-generation antidepressants do not produce clinically significant improvements in depression in patients who initially have moderate or even very severe depression. That’s according to a new meta-analysis of clinical trials research. A triumph for the placebo effect! How does it work?
Read More »
1 Comment »
New concise clinical trials lists and research article abstracts are now available in our medications centre, replacing the comprehensive (but difficult to navigate) set of mental health research abstracts we’ve been accumulating for a few years. If you’re looking for the latest research information on common mental health medications, please check them out and let us know what you think!
Read More »
No Comments »
A new study shows that the results of around a third of drug trials have not been released. Once these are taken into account, the advantage of antidepressants over placebos shrinks significantly. This amounts to seriously misleading the public about the drugs’ effectiveness.
Read More »
2 Comments »
Shire admits there’s a problem with the Daytrana ADHD patch, and fixes it. Following strong feedback from our readers and other users of the Daytrana patch, the company has announced a ‘voluntary market withdrawal’ of faulty Daytrana patches. The company says it is now using an ‘enhanced process’ to ensure the backing of the patch can be easily removed.
Read More »
13 Comments »
If you’ve been following our articles on reader reports about the Daytrana ADHD patch, you’ll know that reader experiences vary widely. With over 170 comments about the methylphenidate transdermal patch, it’s time for another follow-up — and some additional resources for those experiencing problems with the patch.
Read More »
120 Comments »